|
NeuroSearch A/S - Comparative Business Analysis Snapshot
Business Description
NeuroSearch A/S. The Group's principal activity is to invent, develop and market drugs. The Group focuses on research and development of drugs, primarily targeting diseases related to the central nervous system. The products of the Group are sold mainly to the pharmaceutical industry and later on to patients suffering from diseases that are highly disabling such as ADHD, anxiety disorders, cancer, COPD, depression, epilepsy, pain and Parkinson's disease. The Group's research has also led to research and development projects related to other diseases such as obesity, cancer, urinary incontinence and certain heart diseases. The Group operates in the Nordic region.
Competitor Analysis
This analysis compares NeuroSearch A/S with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
